Use of fluroquinolone and risk of Achilles tendon rupture: A population-based cohort study

European Journal of Clinical Pharmacology

Volumn 63, Issue 5, 2007, Pages 499-503

  Sode, Jacob ^a   Obel, Niels ^a   Hallas, Jesper ^b   Lassen, Annmarie ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Achilles tendon; Antibiotics; Cohort study; Incidence; Quinolone

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACHILLES TENDON RUPTURE; ADULT; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; DRUG USE; FEMALE; HUMAN; INCIDENCE; INFORMATION; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK; SEX;

ACHILLES TENDON; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CHILD; COHORT STUDIES; DATABASES; DENMARK; FEMALE; FLUOROQUINOLONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RUPTURE; SEX FACTORS; TENDON INJURIES;

EID: 34147129729     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0265-9     Document Type: Article

References (20)

1. Jarvinen TA, Kannus P, Paavola M et al (2001) Achilles tendon injuries. Curr Opin Rheumatol 13(2):150-155
2. Jarvinen TA, Kannus P, Maffulli N et al (2005) Achilles tendon disorders: etiology and epidemiology. Foot Ankle Clin 10(2):255-266
3. Leppilahti J, Puranen J, Orava S (1996) Incidence of Achilles tendon rupture. Acta Orthop Scand 67(3):277-279
4. Maffulli N, Waterston SW, Squair J et al (1999) Changing incidence of Achilles tendon rupture in Scotland: a 15-year study. Clin J Sport Med 9(3):157-160
5. Houshian S, Tscherning T, Riegels-Nielsen P (1998) The epidemiology of Achilles tendon rupture in a Danish county. Injury 29(9):651-654
6. Levi N (1997) The incidence of Achilles tendon rupture in Copenhagen. Injury 28(4):311-313
7. Suchak AA, Bostick G, Reid D et al (2005) The incidence of Achilles tendon ruptures in Edmonton, Canada. Foot Ankle Int 26(11):932-936
8. Melhus A (2005) Fluoroquinolones and tendon disorders. Expert Opin Drug Saf 4(2):299-309
9. Khaliq Y, Zhanel GG (2003) Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis 36(11):1404-1410
10. van der Linden PD, Sturkenboom MC, Herings RM et al (2002) Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ 324(7349):1306-1307
11. van der Linden PD, Sturkenboom MC, Herings RM et al (2003) Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 163(15):1801-1807
12. van der Linden PD, van de LJ, Nab HW et al (1999) Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol 48(3):433-437
13. Shakibaei M, Pfister K, Schwabe R et al (2000) Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother 44(2):261-266
14. Shakibaei M, de Souza P, van Sickle D et al (2001) Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium-deficient diet. Arch Toxicol 75(6):369-374
15. Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287(5462):2398-2399
16. Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44(4):445-448
17. Rotmann KJ (2006) Epidemiology - an introduction. Oxford Press, Oxford
18. Maclure M (1991) The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 133(2):144-153
19. van der Linden PD, Nab HW, Simonian S et al (2001) Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands. Pharm World Sci 23(3):89-92
20. Goossens H, Ferech M, Vander SR et al (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365(9459):579-587